About
Alessio Lanna is an immunology researcher and biotech founder associated with Sentcell, a company developing T-cell-based rejuvenation therapies. A 2023 FOCIS program lists him as a PhD speaker from Sentcell LTD on immune rejuvenation, and Michael Dustin's CV identifies him as a UCL-affiliated scientist who went on to found Sentcell. Public signals point to a scientist-founder operating in immunology, ageing biology, and translational biotech rather than a professional investor.
Areas of interest
immunologyimmune rejuvenationlongevitybiotechHIV cure researchT-cell biologyageing biology